A UK prospective cohort study suggested that habitual use of glucosamine supplement to relieve osteoarthritis pain might also be related to lower risks of cardiovascular diseases (CVD) events. The study enrolled 466 039 participants from 2006 to 2010. During a median follow-up of 7 years, there were 10 204 incident CVD events, 3060 CVD deaths, 5745 coronary heart disease events, and 3263 stroke events. After adjustment for age, sex, body mass index, race, lifestyle factors, dietary intakes, drug use, and other supplement use, glucosamine use was associated with a significantly lower risk of total CVD events (hazard ratio 0.85), CVD death (0.78), coronary heart disease (0.82), and stroke (0.91). The findings are in line with several previous studies and suggest that glucosamine might have a preventive role in CVD through anti-inflammatory and mimicking a low carbohydrate diet properties. Source: https://www.bmj.com/
A meta-analysis of 15 randomized controlled trials involving 4,824 patients with high blood pressure found…
Higher levels of chronic systemic inflammation were associated with smaller left ventricular volumes, compensatory increases…
In patients with severe asymptomatic carotid artery stenosis, carotid revascularization—either carotid artery stenting (CAS) or…
A 2026 Cochrane systematic review and meta-analysis of 107 randomized trials involving 26,886 adults with…
Higher functional-connectivity-derived brain age deviation was consistently associated with poorer cognitive performance—particularly working memory and…
Higher nighttime light exposure was associated with adverse changes in cardiac structure and function and…
This website uses cookies.